The Multiple Myeloma Research Foundation (MMRF) helps accelerate the development of next generation multiple myeloma treatments to extend patient’s lives, and lead to a cure. MMRF brings treatment to multiple myeloma patients 60% faster than the average through collaboration with best in class partners in the US and Internationally. In the process, we are changing the way cancer research is conducted. MMRF, a 501(c)(3), is the number one private funder of multiple myeloma research in the United States.
The MMRF is working with patients, clinicians, and researchers to speed the development of targeted treatments for multiple myeloma. Watch these videos highlighting the Multiple Myeloma Genomics Initiative (MMGI) research and the importance of personalized medicine in multiple myeloma.